Cargando…

2419. Timing of Secondary Prophylaxis Against Clostridium difficile Infection After Antibiotic Exposure

BACKGROUND: Clostridium difficile infection (CDI) is the most common nosocomial infection, and is increasing. The major risk for CDI is antibiotic (abx) use. We have previously shown that secondary prophylaxis with vancomycin decreases CDI relapse in patients with recent CDI given abx to treat anoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szela, Joel, Hanna, Angy, Sims, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809835/ http://dx.doi.org/10.1093/ofid/ofz360.2097

Ejemplares similares

503. Risk and Timing of Clostridium difficile Infection Relapse After Antibiotic Exposure
por: Szela, Joel, et al.
Publicado: (2018)

496. Secondary Prophylaxis for Clostridium difficile Infection: A Physician Practice Assessment
por: Sampson, Mindy, et al.
Publicado: (2018)

2415. Oral Vancomycin for Secondary Prophylaxis of Clostridium difficile Infections among High-risk Patients
por: Lew, Alison, et al.
Publicado: (2019)

2419. Increasing Misattribution of Bacteremia as CLABSIs by NHSN Definitions: A Tertiary Care Center Perspective
por: Ellsworth, Misti G, et al.
Publicado: (2023)

Efficacy of Oral Vancomycin, Oral Metronidazole, or IV Metronidazole Prophylaxis at Reducing the Risk of Clostridium difficile Recurrence
por: O’Connell, Matthew, et al.
Publicado: (2017)

Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection
por: Zhang, Kevin, et al.
Publicado: (2019)

2419. Standard vs. Alternative Therapy for Stenotrophomonas maltophilia Infections: Focus on Trimethoprim–Sulfamethoxazole, Minocycline, and Moxifloxacin Monotherapy
por: Badwal, Jasmin, et al.
Publicado: (2018)

2413. Assessment of compliance with Clostridioides difficile prophylaxis guideline and its efficacy on secondary prophylaxis and reducing hospital-onset Clostridioides difficile infections.
por: Vyas, Nikunj M, et al.
Publicado: (2019)

1376. Oral Vancomycin as Secondary Prophylaxis Against Clostridioides difficile Infection in Pediatric Patients
por: Bao, Hongkai, et al.
Publicado: (2020)

Etiology of Infectious Diarrhea in Patients Tested for Clostridium difficile: If It Isn’t Clostridium difficile, What Is It?
por: Kwon, Jennie H, et al.
Publicado: (2017)

2421. Efficacy of Secondary Prophylaxis with Oral Vancomycin in Preventing Recurrent Clostridioides difficile Infections in Patients Receiving Systemic Antibiotics
por: Pillinger, Kelly E, et al.
Publicado: (2019)

Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile
por: Balch, Aubrey, et al.
Publicado: (2017)

Antibiotic Exposure and Risk of Community-associated Clostridium difficile infection (CA-CDI): A Self-Controlled Case Series Analysis
por: DiDiodato, Giulio, et al.
Publicado: (2017)

Community acquired Clostridium difficile in an infant without antibiotic exposure
por: Singh, Jaspreet, et al.
Publicado: (2020)

485. On- and Post-Antibiotic Effects on the Risk of Hospital-Acquired Clostridium difficile Infection (CDI)
por: Stevens, Vanessa, et al.
Publicado: (2018)

975. Clostridium difficile Infection and Antibiotic Prescription Rates in the Community: Explaining the Gender Gap
por: Younas, Mariam, et al.
Publicado: (2018)

Antibiotic Prescribing for Dental Procedures in Community-Associated Clostridium difficile cases, Minnesota, 2009–2015
por: Bye, Maria, et al.
Publicado: (2017)

Impact of an Automatic Hospital Probiotic Protocol on Clostridium difficile Infection Rates and Antibiotic Usage Patterns
por: Slain, Douglas, et al.
Publicado: (2017)

519. Longer Length of Antibiotic Therapy for Community-Acquired Pneumonia and Risk of Clostridium difficile Infection
por: Yi, Sarah H, et al.
Publicado: (2018)

Clostridium difficile and Antibiotic-associated Diarrhea
por: Bhattacharyya, Mahuya, et al.
Publicado: (2020)

Antibiotics Associated With Clostridium difficile Infection
por: Rafey, Abdur, et al.
Publicado: (2023)

1593. Recurrence of Clostridium difficile Infection in Multiple Myeloma Patients Receiving Prophylactic Oral Vancomycin or Oral Metronidazole vs. No Prophylaxis
por: Moran, Gisele, et al.
Publicado: (2018)

The Impact of Diagnostic Stewardship on Clostridium difficile Infections
por: Bischoff, Werner, et al.
Publicado: (2017)

514. The Effect of Probiotics on the Incidence of Clostridium difficile
por: Saltzman, Temima, et al.
Publicado: (2018)

2578. Narrow-Spectrum Antibiotic Treatment of Clostridium difficile Infection Improves Preservation of Intestinal Metabolic Profile
por: Park, Seoyoung, et al.
Publicado: (2019)

518. Modeling the Potential Impact of Administering Vaccines Against Clostridium difficile Infection to Individuals in Healthcare Facilities
por: Toth, Damon, et al.
Publicado: (2018)

62. Secondary Prophylaxis in Clostridioides difficile Infections: a Closer Look at Outcomes
por: Rodriguez, Rubi, et al.
Publicado: (2021)

2390. Acquisition of Clostridium difficile Infection Following Exposure from Roommate Defined by Concordance on Genotyping
por: Aslam, Anoshé, et al.
Publicado: (2019)

Endogenous Serum IgG Antibodies to Clostridium difficile Toxin B Are Associated with Protection against C. difficile Infection Recurrence
por: Kelly, Ciaran P, et al.
Publicado: (2017)

973 Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients
por: Stevens, Vanessa, et al.
Publicado: (2014)

470. Concomitant Antibiotic Use and Death Among a National Cohort of Veterans With Clostridium difficile Infection (CDI)
por: Appaneal, Haley, et al.
Publicado: (2018)

Weight Changes in Fecal Microbiota Transplant for Clostridium difficile
por: Hussam, Dina, et al.
Publicado: (2017)

Comparison of Fidaxomicin and Vancomycin for Recurrent Clostridium difficile Colitis
por: Khoo, Teresa, et al.
Publicado: (2017)

536. Clostridium difficile Colonization in the First Year of Life
por: Clayton, Jason A, et al.
Publicado: (2018)

1089. Analytical Performance of an Ultrasensitive Immunoassay for Detection of Clostridium difficile Toxins in Stool
por: Bartolome, Amelita, et al.
Publicado: (2018)

306. Association of Antibiotic Use and Development Secondary Infection from Clostridium difficile, Multidrug-Resistant Bacteria, and Candida in Hospitalized Patients with History of COVID-19
por: Costales, Jessica K, et al.
Publicado: (2021)

Change in Bacterial Diversity of Fecal Microbiota Drives Mortality in a Hamster Model of Antibiotic-induced Clostridium difficile Colitis
por: Burdet, Charles, et al.
Publicado: (2017)

681. Antibiotic Treatment During Hospitalization Is a Major Risk Factor for The Occurrence Of Clostridium Difficile Infection Among Carriers
por: Gilboa, Mayan, et al.
Publicado: (2023)

External validation of predictive scores for mortality following Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

External validation of clinical scores to predict complications of Clostridium difficile infection
por: Beauregard-Paultre, Catherine, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1653bc7cea20qru3grnf7jsquk